Measuring Therapeutic Efficacy in Patients with Alzheimer’s Disease: Role of Instruments

Publisher： Karger

E-ISSN： 1421-9824|31|3|233-238

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.31, Iss.3, 2011-04, pp. : 233-238

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of Rivastigmine in Alzheimer’s Disease Patients with Rapid Disease Progression: Results of a Meta-Analysis

By  

Dementia and Geriatric Cognitive Disorders, Vol. 20, Iss. 2-3, 2005-08 ,pp. : 192-197

Karger

Access to resources Recommend Favorite

The Caregiver’s Role in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 9, Iss. 3, 1998-10 ,pp. : 25-28

Karger

Access to resources Recommend Favorite

A 52-Week Study of the Efficacy of Rivastigmine in Patients with Mild to Moderately Severe Alzheimer’s Disease

By  

European Neurology, Vol. 44, Iss. 4, 2000-11 ,pp. : 236-241

Karger

Access to resources Recommend Favorite

Clinical Efficacy and Safety of Donepezil on Cognitive and Global Function in Patients with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 11, Iss. 6, 2000-10 ,pp. : 299-313

Karger

Access to resources Recommend Favorite

Do Lesions Involving the Cortical Cholinergic Pathways Help or Hinder Efficacy of Donepezil in Patients with Alzheimer’s Disease?

By  

Dementia and Geriatric Cognitive Disorders, Vol. 22, Iss. 5-6, 2006-11 ,pp. : 421-431

Karger

Access to resources Recommend Favorite